RT Journal Article
SR Electronic
T1 COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.24.20042655
DO 10.1101/2020.03.24.20042655
A1 Zhang, Dan
A1 Guo, Rui
A1 Lei, Lei
A1 Liu, Hongjuan
A1 Wang, Yawen
A1 Wang, Yili
A1 Qian, Hongbo
A1 Dai, Tongxin
A1 Zhang, Tianxiao
A1 Lai, Yanjun
A1 Wang, Jingya
A1 Liu, Zhiqiang
A1 Chen, Tianyan
A1 He, Aili
A1 O’Dwyer, Michael
A1 Hu, Jinsong
YR 2020
UL http://medrxiv.org/content/early/2020/03/26/2020.03.24.20042655.abstract
AB Background Excessive monocyte/macrophage activation with the development of a cytokine storm and subsequent acute lung injury, leading to acute respiratory distress syndrome (ARDS) is a feared consequence of infection with COVID-19. The ability to recognize and potentially intervene early in those patients at greatest risk of developing this complication could be of great clinical utility.Methods We performed detailed flow cytometric analysis of peripheral blood samples from 28 COVID-19 patients treated at Xian No.8 Hospital and the First Affiliated Hospital of Xian Jiaotong University in early 2020 in an attempt to identify factors that could help predict severity of disease and patient outcome.Findings While we did not detect significant differences in the number of monocytes between patients with COVID-19 and normal healthy individuals,we did identify significant morphological and functional differences, which are more pronounced in patients requiring prolonged hospitalization and ICU admission. Patients with COVID-19 have larger than normal monocytes, easily identified on forward scatter, side scatter analysis by routine flow cytometry,with the presence of a distinct population of monocytes with high forward scatter (FSC-high). On more detailed analysis, these FSC-high monocytes are CD11b+, CD14+, CD16+, CD68+, CD80+, CD163+, CD206+ and secrete IL-6, IL-10 and TNF-alpha, consistent with an inflammatory phenotype.Conclusions The detection and serial monitoring of this subset of inflammatory monocytes using flow cytometry could be of great help in guiding the prognostication and treatment of patients with COVID-19 and merits further evaluation.Competing Interest StatementJinsong Hu has a pending patient.The other authors declare no conflict of interest.Funding StatementThis study was supported by a Special Fund for COVID-19 from Xi’an Jiaotong University Health Science Center, and the Key Project of Science and Technology of Shaanxi (Grant No. 2018ZDXM-SF-039).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support the findings of this study are available from the corresponding author upon request.